Related Experiment Video
Updated: Jun 24, 2026

Studying Muscle Transcriptional Dynamics at Single-molecule Scales in Drosophila
Published on: September 8, 2023
Smad2 and 3 transcription factors control muscle mass in adulthood
Roberta Sartori1, Giulia Milan, Maria Patron
1Venetian Institute of Molecular Medicine, 35129 Padova, Italy.
Abstract:
Loss of muscle mass occurs in a variety of diseases, including cancer, chronic heart failure, aquired immunodeficiency syndrome, diabetes, and renal failure, often aggravating pathological progression. Preventing muscle wasting by promoting muscle growth has been proposed as a possible therapeutic approach. Myostatin is an important negative modulator of muscle growth during myogenesis, and myostatin inhibitors are attractive drug targets. However, the role of the myostatin pathway in adulthood and the transcription factors involved in the signaling are unclear. Moreover, recent results confirm that other transforming growth factor-beta (TGF-beta) members control muscle mass. Using genetic tools, we perturbed this pathway in adult myofibers, in vivo, to characterize the downstream targets and their ability to control muscle mass. Smad2 and Smad3 are the transcription factors downstream of myostatin/TGF-beta and induce an atrophy program that is muscle RING-finger protein 1 (MuRF1) independent. Furthermore, Smad2/3 inhibition promotes muscle hypertrophy independent of satellite cells but partially dependent of mammalian target of rapamycin (mTOR) signaling. Thus myostatin and Akt pathways cross-talk at different levels. These findings point to myostatin inhibitors as good drugs to promote muscle growth during rehabilitation, especially when they are combined with IGF-1-Akt activators.
Insights
Myostatin inhibitors can promote muscle growth by targeting Smad2/3 transcription factors. This approach aids muscle hypertrophy, particularly when combined with IGF-1-Akt activators for rehabilitation.
Area of Science:
- Muscle physiology
- Molecular biology
- Biochemistry
Background:
- Muscle wasting is a common complication in various diseases, impacting disease progression.
- Myostatin negatively regulates muscle growth, making its inhibitors potential therapeutic targets.
- The adult myostatin pathway's role and its transcription factors remain incompletely understood.
Purpose of the Study:
- To investigate the role of the myostatin pathway in adult muscle mass regulation.
- To identify downstream targets and transcription factors involved in myostatin signaling.
- To explore therapeutic strategies for preventing muscle wasting.
Main Methods:
- Genetic perturbation of the myostatin pathway in adult myofibers in vivo.
- Analysis of downstream targets and their effect on muscle mass.
- Investigating the involvement of Smad2/3, MuRF1, mTOR, and Akt signaling pathways.
Main Results:
- Smad2 and Smad3 are identified as transcription factors downstream of myostatin/TGF-beta.
- Smad2/3 inhibition induces a muscle atrophy program independent of MuRF1.
- Inhibition of Smad2/3 promotes muscle hypertrophy, independent of satellite cells but partially dependent on mTOR signaling.
Conclusions:
- The myostatin and Akt pathways exhibit cross-talk at multiple levels.
- Myostatin inhibitors show promise for promoting muscle growth during rehabilitation.
- Combination therapy with myostatin inhibitors and IGF-1-Akt activators may enhance muscle recovery.
Related Concept Videos
Master Transcription Regulators
Satellite Stem Cells and Muscular Dystrophy
General Transcription Factors
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Transcription Factors
TGF - β Signaling Pathway

